Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 1/2003

01-03-2003 | ORIGINAL ARTICLE

Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval

Authors: Takashi Deguchi, Mitsuru Yasuda, Shigeaki Yokoi, Ken-Ichiro Ishida, Masayasu Ito, Satoshi Ishihara, Ken Minamidate, Yoshimasa Harada, Kanhin Tei, Kentaro Kojima, Masayoshi Tamaki, Shin-Ichi Maeda

Published in: Journal of Infection and Chemotherapy | Issue 1/2003

Login to get access
Metadata
Title
Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval
Authors
Takashi Deguchi
Mitsuru Yasuda
Shigeaki Yokoi
Ken-Ichiro Ishida
Masayasu Ito
Satoshi Ishihara
Ken Minamidate
Yoshimasa Harada
Kanhin Tei
Kentaro Kojima
Masayoshi Tamaki
Shin-Ichi Maeda
Publication date
01-03-2003
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 1/2003
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-002-0204-8

Other articles of this Issue 1/2003

Journal of Infection and Chemotherapy 1/2003 Go to the issue

ORIGINAL ARTICLE

Clinical analysis of pulmonary Mycobacterium avium complex disease in association with corticosteroid treatment

EDITORIAL

Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin

ORIGINAL ARTICLE

Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan

REVIEW ARTICLE

New approaches to developing antimicrobials for resistant bacteria

ORIGINAL ARTICLE

The trend of imported mycoses in Japan

ORIGINAL ARTICLE

Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits